Literature DB >> 25768831

Antimicrobial-impregnated and -coated shunt catheters for prevention of infections in patients with hydrocephalus: a systematic review and meta-analysis.

Athanasios A Konstantelias1, Konstantinos Z Vardakas, Konstantinos A Polyzos, Giannoula S Tansarli, Matthew E Falagas.   

Abstract

OBJECT The aim of this study was to evaluate the effectiveness of antimicrobial-impregnated and -coated shunt catheters (antimicrobial catheters) in reducing the risk of infection in patients undergoing CSF shunting or ventricular drainage. METHODS The PubMed and Scopus databases were searched. Catheter implantation was classified as either shunting (mainly ventriculoperitoneal shunting) or ventricular drainage (mainly external [EVD]). Studies evaluating antibioticimpregnated catheters (AICs), silver-coated catheters (SCCs), and hydrogel-coated catheters (HCCs) were included. A random effects model meta-analysis was performed. RESULTS Thirty-six studies (7 randomized and 29 nonrandomized, 16,796 procedures) were included. The majority of data derive from studies on the effectiveness of AICs, followed by studies on the effectiveness of SCCs. Statistical heterogeneity was observed in several analyses. Antimicrobial shunt catheters (AICs, SCCs) were associated with lower risk for CSF catheter-associated infections than conventional catheters (CCs) (RR 0.44, 95% CI 0.35-0.56). Fewer infections developed in the patients treated with antimicrobial catheters regardless of randomization, number of participating centers, funding, shunting or ventricular drainage, definition of infections, de novo implantation, and rate of infections in the study. There was no difference regarding gram-positive bacteria, all staphylococci, coagulase-negative streptococci, and Staphylococcus aureus, when analyzed separately. On the contrary, the risk for methicillin-resistant S. aureus (MRSA, RR 2.64, 95% CI 1.26-5.51), nonstaphylococcal (RR 1.75, 95% CI 1.22-2.52), and gram-negative bacterial (RR 2.13, 95% CI 1.33-3.43) infections increased with antimicrobial shunt catheters. CONCLUSIONS Based on data mainly from nonrandomized studies, AICs and SCCs reduce the risk for infection in patients undergoing CSF shunting. Future studies should evaluate the higher risk for MRSA and gram-negative infections. Additional trials are needed to investigate the comparative effectiveness of the different types of antimicrobial catheters.

Entities:  

Keywords:  AIC = antibiotic-impregnated catheter; CC = conventional catheter; CSF = cerebrospinal fluid; CoNS = coagulase-negative streptococci; EVD = external ventricular drainage; HCC = hydrogel-coated catheter; MRSA = methicillin-resistant Staphylococcus aureus; RCT = randomized controlled trial; SCC = silver-coated catheter; antibiotic-impregnated catheters; cerebrospinal shunt; external ventricular drainage; hydrocephalus; hydrogel-catheters; infection; silver-coated shunt; ventriculoperitoneal shunt

Mesh:

Substances:

Year:  2015        PMID: 25768831     DOI: 10.3171/2014.12.JNS14908

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  18 in total

1.  Predicting ventriculoperitoneal shunt infection in children with hydrocephalus using artificial neural network.

Authors:  Zohreh Habibi; Abolhasan Ertiaei; Mohammad Sadegh Nikdad; Atefeh Sadat Mirmohseni; Mohsen Afarideh; Vahid Heidari; Hooshang Saberi; Abdolreza Sheikh Rezaei; Farideh Nejat
Journal:  Childs Nerv Syst       Date:  2016-09-14       Impact factor: 1.475

2.  Variations in Strategies to Prevent Ventriculostomy-Related Infections: A Practice Survey.

Authors:  Ariane Lewis; Barry M Czeisler; Aaron S Lord
Journal:  Neurohospitalist       Date:  2016-08-11

Review 3.  Shunt Devices for Neurointensivists: Complications and Management.

Authors:  G Smith; J Pace; A Scoco; G Singh; K Kandregula; S Manjila; C Ramos-Estebanez
Journal:  Neurocrit Care       Date:  2017-10       Impact factor: 3.210

Review 4.  Cerebrospinal Fluid Shunting Complications in Children.

Authors:  Brian W Hanak; Robert H Bonow; Carolyn A Harris; Samuel R Browd
Journal:  Pediatr Neurosurg       Date:  2017-03-02       Impact factor: 1.162

5.  Reduced cell attachment to poly(2-hydroxyethyl methacrylate)-coated ventricular catheters in vitro.

Authors:  Brian W Hanak; Chia-Yun Hsieh; William Donaldson; Samuel R Browd; Kenneth K S Lau; William Shain
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2017-06-20       Impact factor: 3.368

6.  Route of antibiotic prophylaxis for prevention of cerebrospinal fluid-shunt infection.

Authors:  Sebastian Hhmj Arts; Hieronymus Damianus Boogaarts; Erik J van Lindert
Journal:  Cochrane Database Syst Rev       Date:  2019-06-04

7.  Conversion of external ventricular drainage to ventriculo-peritoneal shunt: to change or not to change the proximal catheter?

Authors:  Jehuda Soleman; Haggai Benvenisti; Shlomi Constantini; Jonathan Roth
Journal:  Childs Nerv Syst       Date:  2017-07-24       Impact factor: 1.475

Review 8.  Use of emerging technologies to enhance the treatment paradigm for spontaneous intraventricular hemorrhage.

Authors:  Austin B Carpenter; Jacques Lara-Reyna; Trevor Hardigan; Travis Ladner; Christopher Kellner; Kurt Yaeger
Journal:  Neurosurg Rev       Date:  2021-08-15       Impact factor: 3.042

9.  Evaluation of an in vivo model for ventricular shunt infection: a pilot study using a novel antimicrobial-loaded polymer.

Authors:  Rajiv R Iyer; Noah Gorelick; Karen Carroll; Ari M Blitz; Sarah Beck; Caroline M Garrett; Audrey Monroe; Betty Tyler; Sean T Zuckerman; Jeffrey R Capadona; Horst A von Recum; Mark G Luciano
Journal:  J Neurosurg       Date:  2018-08-03       Impact factor: 5.115

Review 10.  Efficacy of antimicrobial medicated ventricular catheters: a network meta-analysis with trial sequential analysis.

Authors:  Revanth Goda; Akshay Ganeshkumar; Varidh Katiyar; Ravi Sharma; Hitesh Kumar Gurjar; Aprajita Chaturvedi; Roshan Sahu; Hitesh Inder Singh Rai; Zainab Vora
Journal:  Neurosurg Rev       Date:  2021-05-19       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.